JPRN-UMIN000036956
Recruiting
未知
A tau PET study with 18F-THK5351 on neurodegenerative disorders patients. - A tau PET study with 18F-THK5351 on neurodegenerative disorders patients.
agoya City Rehabilitation Agency0 sites150 target enrollmentJune 4, 2019
ConditionsPatients who are suspected neurodegenerative disorders including Alzheimer disease, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, frontotemporal lobe degeneration, Parkinson's disease, dementia with Lewy bodies, and others including possibly tau positive, negative, and inconstant disorders.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Patients who are suspected neurodegenerative disorders including Alzheimer disease, progressive supranuclear palsy, corticobasal degeneration, multiple system atrophy, frontotemporal lobe degeneration, Parkinson'
- Sponsor
- agoya City Rehabilitation Agency
- Enrollment
- 150
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients having history of seizure, alcoholism, or any kind of drug dependency. Patients recognized to be inappropriate by anyone of attending physicians or study staffs.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Multicenter study of [18F]-THK-5351 PET in tauopathiestauopathyJPRN-UMIN000022949ational Center of Neurology and Psychiatry100
Recruiting
Not Applicable
[18F]THK-5351 PET imaging of tau deposits in neurological disorderscorticobasal syndrome, other neurodegenerative disorders, and normal volunteersJPRN-UMIN000021819Tohoku University160
Completed
Phase 2
Novel Neuroimage Study in Tauopathies With ParkinsonismParkinsonismNCT03386669Chang Gung Memorial Hospital44
Recruiting
Not Applicable
A tau PET study for non-AD tauopathiesProgressive Supranuclear PalsyCorticobasal SyndromeMild Cognitive ImpairmentD013494, D000088282, D060825JPRN-jRCT1031230530Takano Harumasa80
Recruiting
Early Phase 1
Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative DisordersNeurodegenerative DisordersNCT04926259First Affiliated Hospital of Fujian Medical University50